Rempart Asset Management Inc. Acquires 2,093 Shares of Stryker Co. (NYSE:SYK)

Rempart Asset Management Inc. lifted its holdings in shares of Stryker Co. (NYSE:SYK - Free Report) by 4.2% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 51,589 shares of the medical technology company's stock after buying an additional 2,093 shares during the period. Stryker comprises about 4.0% of Rempart Asset Management Inc.'s portfolio, making the stock its 12th biggest holding. Rempart Asset Management Inc.'s holdings in Stryker were worth $19,204,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of SYK. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Stryker during the 4th quarter valued at $25,000. Capital A Wealth Management LLC bought a new position in Stryker in the fourth quarter valued at about $26,000. Rakuten Securities Inc. boosted its stake in shares of Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after purchasing an additional 68 shares in the last quarter. Centricity Wealth Management LLC bought a new stake in shares of Stryker during the fourth quarter worth about $30,000. Finally, BankPlus Trust Department bought a new stake in shares of Stryker during the fourth quarter worth about $33,000. 77.09% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the sale, the director now owns 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 5.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on SYK. Citigroup reiterated a "buy" rating and set a $455.00 price target (up previously from $443.00) on shares of Stryker in a report on Thursday, May 22nd. BTIG Research set a $403.00 price target on Stryker and gave the company a "buy" rating in a research note on Monday, April 14th. Roth Mkm lifted their price objective on Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research note on Friday, May 2nd. Barclays upped their target price on Stryker from $418.00 to $443.00 and gave the company an "overweight" rating in a report on Monday, February 10th. Finally, The Goldman Sachs Group set a $422.00 price target on shares of Stryker in a research report on Tuesday, March 4th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $427.30.

Stryker Stock Up 0.1%

NYSE:SYK traded up $0.51 during trading hours on Friday, hitting $382.86. 1,993,145 shares of the company traded hands, compared to its average volume of 1,342,825. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The company has a market cap of $146.13 billion, a PE ratio of 49.34, a PEG ratio of 2.93 and a beta of 0.93. The firm's 50-day simple moving average is $368.77 and its 200-day simple moving average is $376.22.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. Stryker had a net margin of 13.25% and a return on equity of 23.58%. The company had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. During the same period last year, the firm earned $2.50 earnings per share. The firm's revenue was up 11.9% on a year-over-year basis. Equities analysts predict that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date is Monday, June 30th. Stryker's payout ratio is 45.41%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.